Here are four consumer due-diligence questions that FDA's publicly stated concerns make relevant for any buyer evaluating a compounded GLP-1 platform: Does the platform's marketing imply equivalence to FDA-approved drugs
According to a statement provided by the company, "Our CEO Mike Doustdar and EVP, US Operations, Dave Moore were the only two Novo Nordisk representatives in the Oval Office yesterday." Another statement from the company read, "Online speculation led to several media reports incorrectly identifying Gordon Findlay, a Novo Nordisk employee, as the individual at the event
Supports healthy lipid metabolism and assists with reducing visceral belly fat
During your consultation, we'll review your health history, goals, and lab results to develop a customized treatment plan that addresses your specific needs
With daily sublingual drops, the nausea is typically lower intensity but more consistent, presenting as a mild persistent queasiness rather than acute episodes